Logo
Secure Registration

International Conference on Antimicrobial Resistance, Vaccines and Immunology

ICARVI

7th Aug – 8th Aug 2026 Los Angeles, USA

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

10% OFF on Registration.
Use Coupon Code → EARLY10
4

Terms & Condition

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 10
01 Emerging Trends in Antimicrobial Resistance +
This track will explore the latest research on antimicrobial resistance mechanisms and their implications for public health. Discussions will focus on novel strategies to combat resistance and enhance therapeutic efficacy.
SDG 3 SDG 4
02 Innovations in Vaccine Development +
This session will highlight cutting-edge advancements in vaccine technology and formulation. Participants will examine the role of vaccines in preventing infectious diseases and their impact on global health.
SDG 3 SDG 9
03 Immunological Responses to Infectious Pathogens +
This track will delve into the immune system's response to various infectious agents, including bacteria, viruses, and fungi. Researchers will present findings on how these interactions inform vaccine design and therapeutic approaches.
SDG 3 SDG 9
04 Pathogen Surveillance and Public Health Strategies +
This session will focus on the importance of pathogen surveillance in managing infectious diseases. Experts will discuss methodologies for tracking outbreaks and the implications for public health policy.
SDG 3 SDG 16
05 Clinical Research in Infectious Disease Management +
This track will present recent clinical studies aimed at improving the management of infectious diseases. Emphasis will be placed on evidence-based practices and the integration of new therapies into clinical settings.
SDG 3 SDG 9
06 Novel Therapeutics for Drug-Resistant Infections +
This session will explore innovative therapeutic options for treating drug-resistant infections. Researchers will share insights on drug development and the challenges posed by resistant pathogens.
SDG 3 SDG 9
07 Outbreak Control: Strategies and Challenges +
This track will address the multifaceted approaches to controlling infectious disease outbreaks. Discussions will include case studies and the role of interdisciplinary collaboration in outbreak response.
SDG 3 SDG 16
08 Public Health Policy and Antimicrobial Stewardship +
This session will examine the intersection of public health policy and antimicrobial stewardship initiatives. Experts will discuss frameworks for implementing effective policies to mitigate antimicrobial resistance.
SDG 3 SDG 16
09 Global Perspectives on Vaccine Accessibility +
This track will focus on the challenges and solutions related to vaccine accessibility in diverse populations. Participants will analyze global health initiatives aimed at improving vaccine distribution and uptake.
SDG 3 SDG 10
10 The Role of Microbiomes in Immunology +
This session will investigate the influence of microbiomes on immune responses and disease susceptibility. Researchers will present findings on how microbiome modulation can enhance vaccine effectiveness.
SDG 3 SDG 9
11 Ethical Considerations in Infectious Disease Research +
This track will discuss the ethical implications of research in infectious diseases, including vaccine trials and antimicrobial resistance studies. Participants will engage in dialogue about balancing scientific advancement with ethical responsibilities.
SDG 3 SDG 16